Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 4
2007 3
2008 3
2009 3
2010 4
2011 4
2012 2
2013 2
2014 3
2015 4
2016 1
2017 3
2018 4
2019 2
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

39 results
Results by year
Filters applied: . Clear all
Page 1
Antiviral Agents in Development for Zika Virus Infections.
Baz M, Boivin G. Baz M, et al. Pharmaceuticals (Basel). 2019 Jun 29;12(3):101. doi: 10.3390/ph12030101. Pharmaceuticals (Basel). 2019. PMID: 31261947 Free PMC article. Review.
Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus.
Baz M, Carbonneau J, Rhéaume C, Cavanagh MH, Boivin G. Baz M, et al. Viruses. 2018 Nov 3;10(11):610. doi: 10.3390/v10110610. Viruses. 2018. PMID: 30400276 Free PMC article.
Synergistic PA and HA mutations confer mouse adaptation of a contemporary A/H3N2 influenza virus.
Baz M, M'hamdi Z, Carbonneau J, Lavigne S, Couture C, Abed Y, Boivin G. Baz M, et al. Sci Rep. 2019 Nov 12;9(1):16616. doi: 10.1038/s41598-019-51877-4. Sci Rep. 2019. PMID: 31719554 Free PMC article.
H5N1 vaccines in humans.
Baz M, Luke CJ, Cheng X, Jin H, Subbarao K. Baz M, et al. Virus Res. 2013 Dec 5;178(1):78-98. doi: 10.1016/j.virusres.2013.05.006. Epub 2013 May 28. Virus Res. 2013. PMID: 23726847 Free PMC article. Review.
Impact of the Baloxavir-Resistant Polymerase Acid I38T Substitution on the Fitness of Contemporary Influenza A(H1N1)pdm09 and A(H3N2) Strains.
Checkmahomed L, M'hamdi Z, Carbonneau J, Venable MC, Baz M, Abed Y, Boivin G. Checkmahomed L, et al. Among authors: baz m. J Infect Dis. 2020 Jan 1;221(1):63-70. doi: 10.1093/infdis/jiz418. J Infect Dis. 2020. PMID: 31419295
The quest for a nanoparticle-based vaccine inducing broad protection to influenza viruses.
Bolduc M, Baz M, Laliberté-Gagné MÈ, Carignan D, Garneau C, Russel A, Boivin G, Savard P, Leclerc D. Bolduc M, et al. Among authors: baz m. Nanomedicine. 2018 Nov;14(8):2563-2574. doi: 10.1016/j.nano.2018.08.010. Epub 2018 Sep 5. Nanomedicine. 2018. PMID: 30193813
Impact of R152K and R368K neuraminidase catalytic substitutions on in vitro properties and virulence of recombinant A(H1N1)pdm09 viruses.
Tu V, Abed Y, Fage C, Baz M, Boivin G. Tu V, et al. Among authors: baz m. Antiviral Res. 2018 Jun;154:110-115. doi: 10.1016/j.antiviral.2018.04.009. Epub 2018 Apr 16. Antiviral Res. 2018. PMID: 29674164
Predominant role of IPS-1 over TRIF adaptor proteins in early innate immune response against Zika virus in mice.
Piret J, Carbonneau J, Rhéaume C, Baz M, Boivin G. Piret J, et al. Among authors: baz m. J Gen Virol. 2018 Feb;99(2):209-218. doi: 10.1099/jgv.0.000992. Epub 2018 Jan 3. J Gen Virol. 2018. PMID: 29297844
An addition to treatment options for avian influenza A H5N1?
Baz M, Subbarao K. Baz M, et al. Lancet Infect Dis. 2015 Mar;15(3):251-3. doi: 10.1016/S1473-3099(15)70019-8. Epub 2015 Feb 5. Lancet Infect Dis. 2015. PMID: 25662593 No abstract available.
In vitro susceptibility of geographically and temporally distinct Zika viruses to favipiravir and ribavirin.
Baz M, Goyette N, Griffin BD, Kobinger GP, Boivin G. Baz M, et al. Antivir Ther. 2017;22(7):613-618. doi: 10.3851/IMP3180. Epub 2017 Jul 11. Antivir Ther. 2017. PMID: 28694390
39 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page